© 2022 American College of Medical Genetics and Genomics. All rights reserved.
Genetics101 for Healthcare Providers
Date of Release: 2/1/2022
Expiration Date: 2/1/2025
Credits offered: .5 per module
Estimate time of completion: 5 hours
Course/Module must be completed by the expiration date
This course is supported by an independent medical education grant from Illumina, Inc.
Target Audience:
This course is primarily for the non-geneticist healthcare professional.
Accreditation
The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement: The American College of Medical Genetics and Genomics designates this online enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accredited Continuing Education Financial Disclosure
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.
ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACMG Education Policies
Please review the policies below regarding the ACMG Education program
• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy
Financial Support Disclosure Statement: The following course director, program planning committee members, speakers, and staff for this activity, have no financial relationships with ineligible companies relevant to the content of this course.
Fuki M. Hisama, MD, FAAN, FACMG
University of Washington School of Medicine
Nothing to disclose
Content Contributors
Fuki M. Hisama, MD, FAAN, FACMG
University of Washington School of Medicine
Fuki M. Hisama is Professor of Medical Genetics and Adjunct Professor of Neurology at the University of Washington in Seattle. She is a graduate of the University of Chicago Pritzker School of Medicine, completed her Internal Medicine internship at Northwestern Memorial Hospital, and her Neurology residency at Yale New Haven Hospital, where she served as Chief Resident. She completed research and clinical fellowships in Human and Medical Genetics at Yale.
She joined the faculty of the Yale Department of Neurology, where she founded the Adult Neurogenetics Clinic. She moved to Boston Children's Hospital where she was an attending clinical geneticist specializing in pediatric neurogenetics. For the past 12 years, she has been the medical director of the University of Washington Adult Genetic Medicine Clinic, which serves a 5 state region, and she is also the Program Director of the accredited residency in Clinical Genetics and Genomics and Co-PI of an NIH funded T32 postdoctoral Genetics fellowship.
Dr. Hisama has a national reputation as an clinician, scholar and educator in Clinical Genetics and Neurogenetics. She has co-authored over 90 peer reviewed publications, and been interviewed by multiple media outlets including Discover magazine and National Public Radio. She is a lead clinician for the Pacific Northwest Undiagnosed Diseases Clinical Site, and has served in multiple national leadership roles for the Accreditation Council of Graduate Medical Education, the American College of Medical Genetics and Genomics, the Board of Directors of the American Board of Medical Genetics and Genomics, and served as Section Chair of the American Academy of Neurology's Neurogenetics Special Interest Group. She has earned an award from UW School of Medicine for her mentorship of underrepresented faculty and trainees, and in 2020, she received an award for outstanding research mentorship of medical students.
Peer Review
In December of 2021, this continuing medical education online enduring activity was reviewed by Drs. Shweta Dhar and Fuki Hisama. To ensure the continued scientific relevance of this enduring material, its content will be reviewed again prior to the expiry date.
Disclaimer
ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and or exclusive of other procedures and that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.
Questions regarding CE credit should be directed to education@acmg.net